Un document
Highlights
Highlights
❰❱
Actualités
Recent Publication and Patent Application Referencing Apabetalone Support its Continued Development and Success
Calgary, Alberta (ots/PRNewswire) - Nature Reviews Nephrology and Pfizer Inc. discuss BET bromodomain inhibition and apabetalone as viable drug candidates Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today highlighted two additional works involving its lead drug, apabetalone, one recently published ...
plusEQS-Adhoc: AEVIS VICTORIA SA - General Meeting of Shareholders of 13 June 2017
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): AGM/EGM AEVIS VICTORIA SA - General Meeting of Shareholders of 13 June 2017 23-May-2017 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576073 23-May-2017 CET/CEST ...
plusEQS-Adhoc: AEVIS VICTORIA SA publishes a supplement No 5 to the prospectus of its public takeover offer for LifeWatch Ltd.
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Offer AEVIS VICTORIA SA publishes a supplement No 5 to the prospectus of its public takeover offer for LifeWatch Ltd. 23-May-2017 / 07:10 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576295 23-May-2017 CET/CEST ...
plusEQS-Adhoc: LifeWatch AG: BioTelemetry, Inc. announces extension of the main offer period for public offer for LifeWatch AG
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: BioTelemetry, Inc. announces extension of the main offer period for public offer for LifeWatch AG 22-May-2017 / 23:11 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576305 22-May-2017 CET/CEST ...
plusEQS-Adhoc: Leclanché SA: Fire at Leclanché's offices extinguished. All staff are safe. Alternative business continuity plan is being implemented.
EQS Group-Ad-hoc: Leclanché SA / Key word(s): Miscellaneous Leclanché SA: Fire at Leclanché's offices extinguished. All staff are safe. Alternative business continuity plan is being implemented. 22-May-2017 / 18:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576259 22-May-2017 CET/CEST ...
plusAlpine to Provide Cinemo's Multimedia Platform in Latest Infotainment Systems
Karlsruhe (ots) - New project awards to Cinemo further cement the relationship with Alpine in developing seamless next generation in-car entertainment Cinemo, a global leader in high performance and automotive grade multimedia playback, streaming, media management and connectivity middleware, has announced they will be working with Alpine Electronics Inc., a premier ...
plus
Brodalumab, a Novel Biologic for People with Moderate-to-Severe Psoriasis, Receives Positive Opinion from European CHMP
Ballerup, Denmark (ots/PRNewswire) - Opinion from CHMP: "On 18 May 2017, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product [brodalumab], intended for the treatment of psoriasis[...]The benefits with ...
plusZürcher Kantonalbank redeems Additional Tier 1 bond and plans to issue new Additional Tier 1 bond
Zurich (ots) - Zürcher Kantonalbank is calling the Additional Tier 1 bond with a notional amount of CHF 590 million as of 30 June 2017 and intends to issue a new Additional Tier 1 bond. Zürcher Kantonalbank is today announcing the redemption of its ...
Un documentplusBrodalumab, a Novel Biologic for People with Moderate-to-Severe Psoriasis, Receives Positive Opinion from European CHMP
Ballerup, Denmark (ots/PRNewswire) - Opinion from CHMP: "On 18 May 2017, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product [brodalumab], intended for the treatment of psoriasis[...]The benefits with ...
plusMérieux Développement Announces Equity Financing into Xeris Pharmaceuticals
Lyon, France and Boston (ots/PRNewswire) - Mérieux Développement has recently concluded an equity investment into Xeris Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on the development and commercialization of novel formulations of injectable drugs. With this additional financing, Xeris Pharmaceuticals expects to fund registration trials and ...
plusEANS-News: C-QUADRAT founder Alexander Schütz elected to Deutsche Bank Supervisory Board
issuer: C-QUADRAT Investment AG Schottenfeldgasse 20 A-1070 Wien phone: +43 1 515 66-0 FAX: +43 1 515 66-159 mail: c-quadrat@investmentfonds.at WWW: www.c-quadrat.com ISIN: AT0000613005 indexes: stockmarkets: Wien, Frankfurt language: English ...
plusJTI Japan Tobacco International AG
New Extreme EU Tobacco Rules - Brussels Must be Held Accountable for Over-Regulation, Says JTI
Brussels (ots/PRNewswire) - From May 20, tobacco products placed on the market in EU countries will have to comply with the Tobacco Products Directive (TPD2), a raft of draconian rules that will impact consumers and businesses across the Union without meeting its intended goals. (Logo: http://photos.prnewswire.com/prnh/20130528/617491 ) "This is yet another example of ...
plus
Shire Pharmaceuticals Group Plc
Shire to Highlight New Research Into Chronic Hypoparathyroidism at the European Congress of Endocrinology
Zug, Switzerland (ots/PRNewswire) - New clinical and real-life data in chronic hypoparathyroidism, to advance understanding of this rare disease and improve patients' lives Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, announced today new research to be presented on rhPTH(1-84) and on the ...
plusDGAP-Adhoc: LION E-Mobility AG: LION E-Mobility AG invests in Inboard Technology
DGAP-Ad-hoc: LION E-Mobility AG / Key word(s): Investment/Miscellaneous LION E-Mobility AG: LION E-Mobility AG invests in Inboard Technology 18-May-2017 / 19:21 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ...
plusNational Cancer Centre Singapore (NCCS) and Singapore Clinical Research Institute (SCRI)
American Society of Clinical Oncology (ASCO) Publishes Abstract of SIRveNIB, an Investigator-led Asia Pacific Primary Liver Cancer Study to be Presented at ASCO Annual Meeting in Chicago, 4 June 2017
Singapore (ots/PRNewswire) - The SIRveNIB abstract published on-line in the Journal of Clinical Oncology states that treatment of locally advanced Hepatocellular Carcinoma (HCC) with a single treatment of SIR-Spheres® Y-90 resin microspheres results in Overall Survival not significantly different from twice-daily ...
plusShire Pharmaceuticals Group Plc
The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis
Dublin (ots/PRNewswire) - - Study met primary endpoint demonstrating significantly greater remission rates in patients receiving anti-MAdCAM antibody (SHP647) compared to placebo in three of four tested dose groups - First study to investigate the potential role of anti-MAdCAM antibody in the management of ...
plusShire Pharmaceuticals Group Plc
Shire's Investigational Treatment Lanadelumab Reduces Hereditary Angioedema Monthly Attack Rate by 87% Versus Placebo in Phase 3 26-week Pivotal Trial
Lexington, Massachusetts (ots/PRNewswire) - - Significant reduction in monthly Hereditary Angioedema (HAE) attack rate with infrequent subcutaneous administration - Data to serve as basis for U.S. BLA filing expected in Q4 2017 to Q1 2018 - Shire to host Investor Call today at 10 a.m. ET; details below Shire plc ...
plusEQS-Adhoc: AEVIS VICTORIA SA: Integration of Clinique des Tilleuls in Swiss Medical Network
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Offer AEVIS VICTORIA SA: Integration of Clinique des Tilleuls in Swiss Medical Network 18-May-2017 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 574867 18-May-2017 CET/CEST ...
plus
Shaping Cancer Care Today and Tomorrow: Merck to Present New Data from Rapidly Evolving Pipeline at ASCO 2017
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or U.S.-based media ASCO Abstract # M7824 (anti-PD-L1/TGF-ß trap): 3006; Avelumab: 9086, 9530, 9557, 4528, 3059, 5037, e21070, e21065, e20581; Tepotinib: 4087, 8547, e15676, 20541; M3814 (DNA-PK): 2556, e14048; M7583 (BTKi): e14101 - ASCO data highlights ...
plusMerck and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO 2017
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media - A total of 13 abstracts across seven hard-to-treat cancers highlight the progress of avelumab as a monotherapy and potential novel combination treatment option - New data in metastatic Merkel cell carcinoma and ...
plusEarly Response to Saxenda® Resulted in Weight Maintenance and Additional Weight Loss Over 56 Weeks
Porto, Portugal (ots/PRNewswire) - Abstract# RS3:3 Today, results from a post hoc analysis of data from the SCALE Maintenance trial were presented at the 24th European Congress on Obesity (ECO) 2017. In the trial, adults who lost at least 5% of their initial weight during a low- calorie run-in period were randomised ...
plusVolvo Pioneers Autonomous, Self-driving Refuse Truck in the Urban Environment
Gothenburg, Sweden (ots/PRNewswire) - - With Photo In the latest research and development in self-driving vehicles, Volvo Group, together with Swedish waste and recycling specialists Renova, is testing a pioneering autonomous refuse truck that has the potential to be used across the urban environment. The project explores how automation can contribute to enhanced ...
plusEANS-News: Flughafen Wien Group Continues Upswing: Substantial Passenger Growth and Perceptible Earnings Improvement in the First Three Months of 2017
issuer: Flughafen Wien AG Postfach 1 A-1300 Wien-Flughafen phone: +43 1 7007 - 22826 FAX: +43 1 7007 - 23806 mail: investor-relations@viennaairport.com WWW: http://viennaairport.com/unternehmen/investor_relations ISIN: AT00000VIE62 indexes: stockmarkets: Wien language: English ...
plusAtrium European Real Estate Limited
EANS-News: Atrium European Real Estate Limited / First quarter 2017 trading update
issuer: Atrium European Real Estate Limited Seaton Place 11-15 UK-JE4 0QH St Helier Jersey / Channel Islands phone: +44 (0)20 7831 3113 FAX: mail: richard.sunderland@fticonsulting.com WWW: http://www.aere.com ISIN: JE00B3DCF752 indexes: stockmarkets: Wien, Luxembourg Stock Exchange language: English ...
plus
CENX Named "Outstanding Digital Enablement Vendor" by Light Reading's Leading Lights Award Program
Ottawa, Ontario (ots/PRNewswire) - CENX (http://cenx.com/), a global leader in software solutions for the telecom industry, was awarded the "Outstanding Digital Enablement Vendor" award at last night's Leading Lights Award Dinner (https://tmt.knect365.com/leading-lights/) in recognition of its namesake product, ...
plusEANS-News: UNIQA Insurance Group AG / UNIQA completes disposal of Italian subsidiary
issuer: UNIQA Insurance Group AG Untere Donaustraße 21 A-1029 Wien phone: 01/211 75-0 FAX: mail: investor.relations@uniqa.at WWW: http://www.uniqagroup.com ISIN: AT0000821103 indexes: WBI, ATX stockmarkets: Wien language: English ...
plusOrascom Development Holding AG
EQS-Adhoc: Orascom Development Holding AG: The Group improved the operational performance in all business segments across Egypt and Oman. Yet, the significant devaluation of the Egyptian pound of more than 50% in November 2016 had a negative translati...
EQS Group-Ad-hoc: Orascom Development Holding AG / Key word(s): Quarter Results/Quarter Results Orascom Development Holding AG: The Group improved the operational performance in all business segments across Egypt and Oman. Yet, the significant devaluation of the Egyptian pound of more than 50% in November 2016 had ...
plusResverlogix Receives Approval From the FDA Cardiovascular and Renal Division to Proceed With a Requested Apabetalone Clinical Trial
Calgary, Alberta (ots/PRNewswire) - Apabetalone expands to a second major clinical indication in kidney dialysis patients Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce the acceptance, by the Cardiovascular and Renal Products Division of the U.S. Food and Drug Administration ...
plusEANS-News: Kommunalkredit Austria AG / Tender offer relating to CHF bonds completed
issuer: Kommunalkredit Austria AG Türkenstraße 9 A-1092 Wien phone: +43 1 31 6 31 FAX: +43 1 31 6 31 105 mail: kommunal@kommunalkredit.at WWW: www.kommunalkredit.at ISIN: - indexes: stockmarkets: Luxembourg Stock Exchange, Wien, SIX Swiss Exchange language: English ...
plusEANS-News: Rosenbauer International AG / Supervisory Board and Executive Board thank Gottfried Brunbauer for his successes on the Executive Board (with photo)
http://resources.euroadhoc.com/us/ja00WU7t company: Rosenbauer International AG Paschingerstrasse 90 A-4060 Leonding phone: +43(0)732 6794 568 FAX: +43(0)732 6794 89 mail: ir@rosenbauer.com WWW: www.rosenbauer.com sector: Machine Manufacturing ISIN: AT0000922554 indexes: WBI, ATX Prime stockmarkets: free trade: ...
plus
Précédent192193194195196197198199200201Suivant